Performance of urine test in patients monitored for recurrence of bladder cancer: A multicenter study in the United States

Journal of Urology

Volumn 174, Issue 4 I, 2005, Pages 1238-1241

  Messing, Edward M ^a,e   Teot, Lisa ^a   Korman, Howard ^b   Underhill, Jeanne ^b   Barker, Edward ^c   Stork, Brian ^c   Qian, Junqi ^d   Bostwick, David G ^d  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c Medical Laboratory Associates   (United States)

^d BOSTWICK LABORATORIES   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Bladder; Bladder neoplasms; Cytology; Neoplasm recurrence

Indexed keywords

ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTOSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED STATES; URINALYSIS;

EID: 24944543919     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000173918.84006.4d     Document Type: Article

References (23)

1. American Cancer Society. Cancer Facts and Figures, 2004. Statistics 2004
2. Pfister, C., Chautard, D., Devonec, M., Perrin, P., Chopin, D., Rischman, P. et al: Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol, 169: 921, 2003
3. Fradet, Y.: Recent advances in the management of superficial bladder tumors. Can J Urol, 9: 1544, 2002
4. Messing, E. M., Young, T. B., Hunt, V. B., Gilchrist, K. W., Newton, M. A., Bram, L. L. et al: Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology, 45: 387, 1995
5. Bubendorf, L., Grilli, B., Sauter, G., Mihatsch, M. J., Gasser, T. C. and Dalquen, P.: Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol, 116: 79, 2001
6. Fradet, Y. and Lockhard, C.: Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt™. Can J Urol, 4: 400, 1997
7. Olsson, H. and Zackrisson, B.: ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma. Scand J Urol Nephrol, 35: 280, 2001
8. Lodde, M., Mian, C., Negri, G., Berner, L., Maffei, N., Lusardi, L. et al: Role of uCyt+ in the detection and surveillance of urothelial carcinoma. Urology, 61: 243, 2003
9. Mian, C., Lodde, M., Comploj, E., Negri, G., Egarter-Vigl, E., Lusuardi, L. et al: Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion® Multicolour-FISH in the detection of urothelial carcinoma. Cytopathology, 14: 338, 2003
10. Tetu, B., Tiguert, R., Harel, F. and Fradet, Y.: ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Mod Pathol, 18: 83, 2004
11. Lopez, B. M., Aparicio, T. F., Martinez-Valls, G., Villa-Plana, G. H., Garcia, J. L. and Benito, A. C.: Validez del ImmunoCyt en el diagnostico y seguimiento de las neoplasias vesicales uroteliales. Asoc Esp Urol, abstract C55, 2002
12. Toma, M. I., Friedrich, M. G., Hautmann, S. H., Jakel, K. T., Erbersdobler, A., Hellstern, A. et al: Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol, 22: 145, 2004
13. Vriesema, J. L., Atsma, F., Kiemeney, L. A., Peelen, W. P., Witjes, J. A. and Schalken, J. A.: Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence. Urology, 58: 367, 2001
14. Lodde, M., Mian, C., Pycha, A., Wiener, H. and Marberger, M.: Immunocyt™ for the detection of transitional cell cancer of the urinary tract. J Urol, suppl., 161: 150, abstract 574, 1999
15. Bunting, P., Fleshner, N., Kapusta, L., Hersey, K. and Klotz, L.: Detection of bladder cancer via non-invasive methods: a direct comparison of the NMP-22 and immunocyte test. J Urol, suppl., 163: 134, abstract 592, 2000
16. Ceil, G., Zumbragel, A., Paulgen-Nelder, H. J., Hennenlotter, J., Maurer, S., Krauser, S. et al: Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder. Anticancer Res, 23: 963, 2003
17. Mian, C., Lodde, M., Comploj, E., Palmermo, S., Mian, M., Marziani, F. et al: The UCYT+ Test: an update. Eur Urol, 41: abstract 627, 2005
18. Boman, H., Hedelin, H. and Holmäng, S.: Four bladder tumor markers have a disappointing low sensitivity for small size and low grade recurrence. J Urol, 167: 80, 2002
19. Tinzl, M., Marberger, M., Horvath, S. and Chypre, C.: DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer. Eur Urol, 46: 182, 2004
20. Grossman, H. B., Gomella, L. G., Fradet, Y., Presti, J. C., Jr., Ritenour, C. W. M., Lerner, S. P. et al: The use of Hexvix and fluorescence cystoscopy as an adjuct in the diagnosis of stage TA/T1 urothelial cancer in the urinary bladder. J Urol, suppl., 171: 69, abstract 263, 2004
21. Leyh, H., Marberger, M., Conort, P., Sternberg, C., Pasadoro, V., Pagano, F. et al: Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur Urol, 35: 52, 1999
22. Sarosdy, M. F., Schellhammer, P., Bokinsky, G., Kahn, P., Chao, R., Yore, L. et al: Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol, 168: 1950, 2002
23. Lodde, M., Mian, C., Negri, G., Vittadello, F., Comploj, E., Palermo, S. et al: Effect of intravesical instillation on performance of uCYT+ test. Urology, 63: 878, 2004